Cargando…
In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma
Cholangiocarcinoma (CCA) is a heterogenous group of malignancies in the bile duct, which proliferates aggressively. CCA is highly prevalent in Northeastern Thailand wherein it is associated with liver fluke infection, or Opisthorchis viverrini (OV). Most patients are diagnosed in advanced stages, wh...
Autores principales: | Balasubramanian, Brinda, Venkatraman, Simran, Myint, Kyaw Zwar, Krobthong, Sucheewin, Wongtrakoongate, Patompon, Sripa, Jittiyawadee, Rattanasinganchan, Panthip, Metheenukul, Pornphimon, Tohtong, Rutaiwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351686/ https://www.ncbi.nlm.nih.gov/pubmed/35889537 http://dx.doi.org/10.3390/molecules27144664 |
Ejemplares similares
-
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
por: Balasubramanian, Brinda, et al.
Publicado: (2021) -
Gadd45β silencing impaired viability and metastatic phenotypes in cholangiocarcinoma cells by modulating the EMT pathway
por: Myint, Kyaw Zwar, et al.
Publicado: (2018) -
Porcine placenta extract improves high-glucose-induced angiogenesis impairment
por: Nensat, Chatchai, et al.
Publicado: (2021) -
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2021) -
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2023)